Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Jinshui, Tan"'
Autor:
Manman Deng, Jinshui Tan, Ziying Fan, Lan V. Pham, Feng Zhu, Xiaosheng Fang, Haijun Zhao, Kenh Young, Bing Xu
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-10 (2023)
Abstract High grade B-cell lymphoma with MYC and BCL2 rearrangements (HGBCL-DH) represents an uncommon B-cell lymphoma (BCL) with aggressive clinical courses and poor prognosis. Despite revolutionary therapeutic advances in BCL, there has been limite
Externí odkaz:
https://doaj.org/article/d3761ed026544611b02effc0bda6a9eb
Autor:
Jinshui Tan, Mengya Zhong, Yanyan Hu, Guangchao Pan, Jingwei Yao, Yuanfang Tang, Hongpeng Duan, Yuelong Jiang, Weihang Shan, Jiaqi Lin, Yating Liu, Jiewen Huang, Huijian Zheng, Yong Zhou, Guo Fu, Zhifeng Li, Bing Xu, Jie Zha
Publikováno v:
Discover Oncology, Vol 14, Iss 1, Pp 1-15 (2023)
Abstract Refractory or relapsed (R/R) AML is the most challenging form of AML to treat. Due to frequent genetic mutations, therapy alternatives are limited. Here, we identified the role of ritanserin and its target DGKα in AML. Several AML cell line
Externí odkaz:
https://doaj.org/article/ed795b3fcb3644ed9cb15069fa02179c
Autor:
Haijun Zhao, Yuelong Jiang, Fusheng Lin, Mengya Zhong, Jinshui Tan, Yong Zhou, Long Liu, Guowei Li, Manman Deng, Bing Xu
Publikováno v:
Experimental Hematology & Oncology, Vol 11, Iss 1, Pp 1-14 (2022)
Abstract Background Leukemia stem cells (LSCs) are responsible for the initiation and perpetuation of acute myeloid leukemia (AML), and also represent leukemia relapse reservoirs with limited therapeutic approaches. Thus, additional treatment strateg
Externí odkaz:
https://doaj.org/article/8041ed2f41ae4be8952ae24cc4b778f9
Autor:
Zhengxin Wu, Jinshui Tan, Yifan Zhuang, Mengya Zhong, Yubo Xiong, Jingsong Ma, Yan Yang, Zhi Gao, Jiabao Zhao, Zhijian Ye, Huiwen Zhou, Yuekun Zhu, Haijie Lu, Xuehui Hong
Publikováno v:
Cancer Cell International, Vol 21, Iss 1, Pp 1-13 (2021)
Abstract Background Metabolic reprogramming has been reported in various kinds of cancers and is related to clinical prognosis, but the prognostic role of pyrimidine metabolism in gastric cancer (GC) remains unclear. Methods Here, we employed DEG ana
Externí odkaz:
https://doaj.org/article/7f2bf3d552e143838ed1267ad59a64e8
Autor:
Mengya Zhong, Jinshui Tan, Guangchao Pan, Yuelong Jiang, Hui Zhou, Qian Lai, Qinwei Chen, Liyuan Fan, Manman Deng, Bing Xu, Jie Zha
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
The key factors leading to transformed follicular lymphoma (t-FL) include the aberrations of epigenetic modifiers as early and driving events, especially mutations in the gene encoding for histone acetyltransferase. Therefore, reversal of this phenom
Externí odkaz:
https://doaj.org/article/3d713885de444a33b83a276132d8180e
Autor:
Yuanfang Tang, Mengya Zhong, Guangchao Pan, Jinshui Tan, Chendi Xie, Yuelong Jiang, Jingwei Yao, Weihang Shan, Jiaqi Lin, Jiewen Huang, Yating Liu, Zhifeng Li, Bing Xu, Jie Zha
Publikováno v:
Pharmaceuticals, Vol 16, Iss 1, p 15 (2022)
Transformed follicular lymphoma (t-FL), for which there is no efficient treatment strategy, has a rapid progression, treatment resistance, and poor prognosis, which are the main reasons for FL treatment failure. In this study, we identified a promisi
Externí odkaz:
https://doaj.org/article/40f2f2cd18014b5ab8bc4a9c0019fd00
Autor:
Xinguo Zhuang, Jingwei Yao, Xun Li, Yuelong Jiang, Mengya Zhong, Jinshui Tan, Hui Zhou, Genhong Li, Jie Zha, Bing Xu
Publikováno v:
International Journal of Medical Sciences; 2024, Vol. 21 Issue 1, p70-79, 10p
Autor:
Huiwen Zhou, Mengya Zhong, Zhengxin Wu, Zhijian Ye, Xuehui Hong, Jiabao Zhao, Yifan Zhuang, Yubo Xiong, Yan Yang, Haijie Lu, Yuekun Zhu, Jinshui Tan, Jingsong Ma, Zhi Gao
Publikováno v:
Cancer Cell International, Vol 21, Iss 1, Pp 1-13 (2021)
Cancer Cell International
Cancer Cell International
Background Metabolic reprogramming has been reported in various kinds of cancers and is related to clinical prognosis, but the prognostic role of pyrimidine metabolism in gastric cancer (GC) remains unclear. Methods Here, we employed DEG analysis to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a51948c47742654f28b1db5440dcad56
https://doaj.org/article/7f2bf3d552e143838ed1267ad59a64e8
https://doaj.org/article/7f2bf3d552e143838ed1267ad59a64e8
Autor:
Jie Zha, Mengya Zhong, Guangchao Pan, Qinwei Chen, Yuelong Jiang, Qian Lai, Jinshui Tan, Hui Zhou, Hua Wu, Bing Xu
Publikováno v:
Gene. 856:147110
Optimizing prognostic stratification of patients with cytogenetic normal acute myeloid leukemia (CN-AML), a highly heterogeneous subgroup in AML, appears to be important to improve its treatment and clinical outcome. Here, we report a potential role
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c843b7fff1a79cff33ac38d130986e0a
https://doi.org/10.1016/j.gene.2022.147110
https://doi.org/10.1016/j.gene.2022.147110
Autor:
Hui, Zhou, Yuelong, Jiang, Yuetin, Huang, Mengya, Zhong, Dongmei, Qin, Chendi, Xie, Guangchao, Pan, Jinshui, Tan, Manman, Deng, Haijun, Zhao, Yong, Zhou, Yuanfang, Tang, Qian, Lai, Zhihong, Fang, Yiming, Luo, Yirong, Jiang, Bing, Xu, Jie, Zha
Publikováno v:
Cancer Letters. 554:215997
Treatment of acute myeloid leukemia (AML) with chemotherapeutic agents fails to eliminate leukemia stem cells (LSC)，and thus patients remain at high risk for relapse. Therefore, the identification of agents that target LSC is an important considera
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f688de3d8d710761210952b0862a4859
https://doi.org/10.1016/j.canlet.2022.215997
https://doi.org/10.1016/j.canlet.2022.215997